Showing 1501-1510 of 4065 results for "".
Consensus and Standards to Improve Continuity of Care in Sickle Cell Disease
https://reachmd.com/programs/clinicians-roundtable/consensus-and-standards-to-imrpove-continuity-of-care-in-sickle-cell-disease/24061/The CellFX System from Pulse Biosciences
https://reachmd.com/topics/energy-based-devices/the-cellfx-system-from-pulse-biosciences/35181/Vutrisiran for ATTR-CM: Exploring an RNAi Therapeutic
https://reachmd.com/programs/spotlight-attr-cm/vutrisiran-for-attr-cm-exploring-an-rnai-therapeutic/32419/Read about recent clinical trial findings on vutrisiran, an RNA interference therapeutic that has emerged as a potential option for patients with transthyretin amyloid cardiomyopathy.Disparities in Acne Prescribing Patterns Highlight Structural and Racial Gaps
https://reachmd.com/programs/clinicians-roundtable/acne-prescribing-disparities-structural-racial-gaps/49091/Anti-VEGF Use in Retinal Vein Occlusion: Insights from a Real-World Cohort
https://reachmd.com/programs/eye-on-ocular-health/anti-vegf-use-in-retinal-vein-occlusion-insights-from-a-real-world-cohort/37662/Validating hf-PGA for Hand and Foot Psoriasis Severity in Adults
https://reachmd.com/programs/dermconsult/hf-pga-hand-foot-psoriasis-severity-adults/39681/Dr. Google Is a Liar
https://reachmd.com/programs/book-club/dr-google-liar/10612/With many patients turning to the internet for the answer to their symptoms and ailments, how can we as healthcare providers win the information war?Bronchiectasis Update: Diagnostic Innovations and Therapeutic Frontiers
https://reachmd.com/programs/cme/bronchiectasis-update-diagnostic-innovations-and-therapeutic-frontiers/37233/Bronchiectasis is complex, often underdiagnosed, and frequently misunderstood. Explore key contributors to disease progression, including the role of neutrophilic inflammation and neutrophilic serine proteases, and learn to distinguish bronchiectasis from other respiratory conditions and assess patiEnlisting Students in the Fight Against COVID-19: Helpful or Harmful?
https://reachmd.com/programs/covid-19-frontlines/enlisting-students-fight-against-covid-19-helpful-or-harmful/11325/Medical students are increasingly being thrust into frontline efforts to combat COVID-19. Will this help stem the tide, or compound the crisis?Understanding the Mechanism Behind a Treatment Approach in Indolent Systemic Mastocytosis (ISM)
https://reachmd.com/programs/medical-industry-feature/mechanism-treatment-approach-indolent-systemic-mastocytosis-ism/32766/Historically, indolent systemic mastocytosis (ISM) care focused on treating symptoms. AYVAKIT® (avapritinib) targets the KIT D816V mutation, the underlying cause of ISM.3,4 Learn how AYVAKIT can play a role in treating patients with ISM.1